Described by Forbes as the company’s “savvy CEO”, Diane Scott brings over 20 years of global experience in the C-suite of enterprises in emerging industries to her role of Group Chair and CEO of the JMCC Group of Companies.
Named as one of North America’s 2019 top female CEOs in the industry by MJ Business Magazine, Diane helms a rapidly growing business with contracted revenues from customers in Canada, Germany, Australia and Brazil, and which is on-plan to deliver nearly one million square feet of medical cannabis cultivation by early 2020.
In addition to her JMCC role, Diane is also Co-founder of SX2 Ventures, an international venture capital firm business based in London, which focuses on innovation and value creation in the human care sector, investing in life sciences, longevity, specialized care and emerging market healthcare solutions. SX2’s founders share the belief that business and capital must always benefit humanity: hence, every investment by SX2 has a strong social “give-back” component.
Diane is also an Advisor to the Center for Medicinal Cannabis in the United Kingdom, a group working to help shape the U.K.’s new medicinal cannabis regime.